General Information
Official company information
- Registry ID
-
9300813Registry ID - A unique identifier for this business
- Company Age
- 9 years
- Registration Date
-
- Registered Address
-
1100 Boul. René-Lévesque O #1110, Montréal, QC H3B 4N4
- Business Number (BN)
- 821124369RC0001
- City
- Montréal
- Status Notes
- 2015-05-20
- Phone
- Website
-
Official company website with more information about products, services, and contact details.
About INVERSAGO PHARMA INC.
Company profile and description
Inversago Pharma is a clinical-stage biopharmaceutical company dedicated to developing therapies for patients suffering from metabolic and fibrotic diseases. Based in Montreal, Canada, Inversago is the leader in the development of peripherally-acting CB1 receptor (CB1r) blocker therapies. The company's lead program, INV-202, targets metabolic disorders and is being evaluated in Phase 2 studies for diabetic kidney disease and obesity.
Category
Business category and classification details
- Primary Category
- Health & Medical
- Description
- Providers of medical, dental, therapeutic, and other health-related services, including hospitals, clinics, private practices, and pharmacies.
Additional Information
Detailed company information and status
- Version
- 1808577316121477120
- Hierarchy
- parent
- Entity Type
- Business Corporation
- Display Date
- 2015-05-20
- Jurisdiction
- CC
- Business Number
- 821124369RC0001
- MRAS Entity Type
- BCA
- Juri ID Alternate
- 930081-3
Company Contacts
Key contacts and leadership 3 total contacts
| Name & Position | Contact Number | Fax Number | |
|---|---|---|---|
|
F
François Ravenelle
chief executive officer
|
-
|
-
|
-
|
|
P
Philippe Périou
Media
|
-
|
-
|
|
|
G
Glenn S. Vraniak
Investors
|
+15134762669
|
-
|
Similar Companies
Companies in the same industry or category
-
Health & Medical -
Health & Medical -
Health & Medical -
Health & Medical
In the News
Recent media coverage and press mentions
No recent media coverage
No recent news articles found for INVERSAGO PHARMA INC.
